Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.24.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

($ in thousands)

    

2024

    

2023

​

2024

    

2023

Fortress:

​

​

​

​

​

​

​

​

​

​

​

​

Employee and non-employee awards

​

$

2,385

​

$

2,077

​

$

6,827

​

$

6,785

Executive awards

​

 

276

​

 

385

​

 

772

​

 

1,202

​

​

​

​

​

​

​

​

​

​

​

​

​

Partner Companies:

​

 

​

​

​

​

​

​

​

​

​

​

Avenue

​

 

331

​

 

561

​

 

714

​

 

599

Checkpoint

​

 

1,611

​

 

689

​

 

3,491

​

 

2,225

Mustang

​

 

42

​

 

100

​

 

(500)

​

 

380

Journey

​

​

1,640

​

​

558

​

​

4,720

​

​

2,077

Other

​

 

288

​

 

7

​

 

405

​

 

57

Total stock-based compensation expense

​

$

6,573

​

$

4,377

​

$

16,429

​

$

13,325

Schedule of Stock Option Activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average

​

​

​

​

​

​

​

Total

​

remaining

​

​

​

​

Weighted average

​

weighted average

​

contractual life

​

    

Number of shares

    

exercise price

    

intrinsic value

    

(years)

Options vested and expected to vest at December 31, 2023

 

18,896

​

$

20.55

​

$

—

 

1.76

Granted

​

540,000

​

​

1.68

​

​

—

​

6.45

Options vested and expected to vest at September 30, 2024

 

558,896

​

$

2.32

​

$

—

 

6.27

Options vested and exercisable at September 30, 2024

​

18,896

​

$

20.55

​

$

—

 

1.01

Schedule of Restricted Stock Awards and Restricted Stock Units

​

​

​

​

​

​

​

​

    

​

    

Weighted

​

​

​

​

average grant

​

​

Number of shares

​

price

Unvested balance at December 31, 2023

​

1,458,700

​

$

28.05

Restricted stock granted

​

443,025

​

​

3.01

Restricted stock vested

​

(22,969)

​

​

35.67

Restricted stock units granted

​

37,500

​

​

39.61

Restricted stock units forfeited

​

(19,485)

​

​

14.56

Restricted stock units vested

​

(102,529)

​

​

39.61

Unvested balance at September 30, 2024

​

1,794,242

​

$

21.49

Schedule of Warrant activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total weighted

​

Weighted average

​

​

​

​

​

​

​

average

​

remaining

​

​

Number of

​

Weighted average

​

 intrinsic

​

contractual life

​

    

shares

    

exercise price

    

value

    

(years)

Outstanding as of December 31, 2023

 

5,787,289

​

$

1.88

​

$

7,794,450

 

4.91

Issued

​

8,729,746

​

​

2.35

​

​

—

​

—

Exercised

​

(17,500)

​

​

1.70

​

​

—

​

—

Outstanding as of September 30, 2024

 

14,499,535

​

$

2.16

​

$

—

 

4.71

Exercisable as of September 30, 2024

 

14,499,535

​

$

2.16

​

$

—

 

4.71